IDEXX Laboratories is experiencing a positive shift in its stock performance, reflecting investor confidence.
IDEXX Laboratories Inc (NASDAQ:IDXX) is rising today, with shares up by 1.07% to close at CA$525.87. This upward movement comes as the company continues to demonstrate strong performance in the veterinary diagnostics sector.
Investor takeaway: Investors may see IDEXX's recent developments and strategic initiatives as a positive sign for future growth, contributing to the stock's rise today.
Advertisement
IDEXX Laboratories Inc
IDXX.US
IDXX.US
IDEXX Laboratories Inc
WealthAwesomeMarket cap
$41.68B
P/E
36.6x
52W high
$769.98
52W low
$500.61
1W change
+6.63%
Beta
1.55
Analyst Price Targets
Based on 13 analysts covering IDXX · as of Oct 5, 2026
Wall Street analysts forecast IDXX stock price to rise 28.2% over the next 12 months.
Consensus
Buy3.85 / 5.00
Avg. Target
C$701.33
+28.2% Upside
Current Price
C$547.18
Last close
Analyst Breakdown (13 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on IDXX's historical volatility
30-Day Vol
23.9%
Annualized
90-Day Vol
29.3%
Annualized
Trend (90d)
+1.7%
Annualized drift
90d Mean
C$550.47
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$548.27 | C$504.91 – C$595.36 |
| 60 trading days | C$549.37 | C$488.95 – C$617.25 |
| 90 trading days | C$550.47 | C$477.26 – C$634.90 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Market Cap Reaches CA$40.99 Billion
With a market cap of CA$40.99 billion, IDEXX continues to be a significant player in the veterinary diagnostics space, reflecting strong investor interest.
Bull case
The recent acquisition of CoVetAI and the expansion of diagnostic testing capabilities position IDEXX for ongoing growth and innovation in the veterinary market. These moves show IDEXX's commitment to enhancing its offerings and staying ahead in a competitive industry.
Bear case
Despite the current gains, IDEXX faces challenges like high P/E ratios and market volatility that could affect future performance. Investors should keep an eye on these factors as they navigate their investment decisions.
Strong Financial Performance
Advertisement
IDEXX's recent financial results indicate robust growth, particularly in the Companion Animal Group Diagnostics segment. This strong performance is likely contributing to the positive sentiment around the stock today.
Innovative Acquisitions and Expansions
The acquisition of CoVetAI and the launch of new diagnostic tests highlight IDEXX's commitment to innovation. These strategic moves are expected to enhance its market position and drive future revenue growth.
Market Outlook
As IDEXX continues to expand its capabilities and product offerings, investors are optimistic about the company's long-term prospects. However, they should remain cautious of potential market fluctuations that could impact stock performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
